Glyceraldehyde-3-phosphate dehydrogenase and apoptosis

Journal of Neuroscience Research

Volumn 60, Issue 2, 2000, Pages 150-154

  Berry, M D ^a   Boulton, A A ^a,b  

^a ALviva Biopharmaceuticals Inc   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Alzheimer's disease; Anti apoptotic; Huntington's disease; Neurodegeneration

Indexed keywords

DRUG METABOLITE; ESTRADIOL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; SELEGILINE;

ALZHEIMER DISEASE; APOPTOSIS; DEGENERATIVE DISEASE; ENZYME MECHANISM; HUMAN; HUNTINGTON CHOREA; HYPOXIA; ISCHEMIA; MUSCLE ATROPHY; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; APOPTOSIS; BRAIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS;

EID: 0034656409     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO;2-4     Document Type: Short Survey

References (63)

1. Allen DL. Linderman JK, Roy RR, Bigbee AJ, Grindland RE, Mukku V, Edgerton VR. 1997. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb tinweighnng. Am J Physiol 273:C579-C587.
2. p4A binding protein. Biochemistry 34:9700-9707.
3. Berry MD. 1999. R-2HMP, an orally active agent combining independent anti-apoptotic and MAO-B inhibitory activities. CNS Drug Rev 5:105-124.
4. Burke JR, Enghild JJ, Martin ME, Jou Y-S, Myers RM, Roses AD, Vance JM, Strittmatter WJ. 1996. Huntingtin and DRLPA proteins selectively interact with the enzyme GAPDH. Nat Med 2:347-350.
5. Boulton AA, Davis BA, Durden, DA, Dyck, LE, Juorio AV, Li, X-M, Paterson IA, Yu PH. 1997. Aliphatic propargylamines - new antiapoptotic drugs. Drug Dev Res 42:150-156.
6. Carhle GW, Tatton WG, Borden KLB. 1998. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem J 335: 691-696.
7. Carlile GW, Chalmers-Redman RME, Tatton NA, Borden KLB, Tatton WG. 2000. Reduced apoptosis after NGF and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol Pharmacol (in press).
8. Chen RW, Saunders PA, Wei HF, Li ZG, Seth P, Chuang D-M. 1999. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. J Neurosci. 19:9654-9662.
9. Cros N, Muller J, Bouju S, Piétu G, Jacquet C, Léger JJ, Marini J-F, Dechesne CA. 1999. Upregulation of M-creatine kinase and glyceraldehyde-3-phosphate dehydrogenase: two markers of muscle disuse. Am J Physiol 276:R308-R316.
10. Dragunow M, Faull RLM, Lawlor P. Beilharz EJ, Singleton K, Walker EB, Mee E. 1995. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport 6:1053-1057.
11. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. 1998. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253-1258.
12. Edwards YH, Clark P, Harros H. 1976. Isozymes of glyceraldehyde-3-phosphate dehydrogenase in man and other mammals. Ann Hum Genet 40:67-77.
13. Enokido Y, Araki T, Aizawa S, Hatanaka H. 1996. p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons. Neurosci Lett 203:1-4.
14. Feldhaus LM, Liedtke AJ. 1998. mRNA expression of glycolytic enzymes and glucose transporter proteins in ischémic myocardium with and without reperfusion. J Mol Oil Cardiol 30:2475-2485.
15. Gentile V, Sepe C, Calvani M, Melone MAB, Cotrufo R, Cooper AJL, Blass JP, Peluso G. 1998. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys 352:314-321.
16. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR. 1996. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13:442-449.
17. Goodman Y, Bruce AJ, Cheng B, Mattson MP. 1996. Estragens attenuate and corticosterone exarcebates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844.
18. Graven KK, Farber HW. 1998. Endothelial cell hypoxic stress proteins. J Lab Clin Med 132:456-463.
19. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A. 1996. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 13:196-202.
20. Ishitani R, Chuang D-M. 1996. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA 93:9937-9941.
21. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang D-M. 1996a. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmac Exp Ther 278:447-454.
22. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang D-M. 1996b. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 66:928-935.
23. +-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol Pharmacol 51:542-550.
24. Ishitani K, Tanaka M, Sunaga K, Katsube N, Chuang D-M. 1998. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53:701-707.
25. Ito Y, Pagano PJ, Tornheim K, Brecher P, Cohen RA. 1996. Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta. Am J Physiol 270:H81-H87.
26. Joe I, Jackson G, Ramirez VD. 1999. Further study of the enzymatic activity of glyceraldehyde-3-phosphate-dehydrogenase in subcellular fractions of rat brains. Soc Neurosci Abs 25:167.16.
27. Katsube N, Sunaga K, Aishita H, Chuang D-M, Ishitani R. 1999. ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons. J Pharmac Exp Ther 288:6-13.
28. Kish SJ, Lopes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross BM, Nance M, Schut L, Ang L, DiStefano L. 1998. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Arch Neurol 55:1299-1304.
29. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT. 1998. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53.
30. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY. 1996. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5:1311-1318.
31. Kragten E, Lalande I, Zimmermann K, Roggo S, Schindler P, Müller D, van Oostrum J, Waldmeier P, Fürst P. 1998. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-Deprenyl. J Biol Chem 273:5821-5828.
32. Kremer B, Goldeberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, Squitieri F, Lin B, Bassett A. 1994. Worldwide study of the Huntington's disease mutation: the sensitivity and specificity of repeated CAG sequences. N Engl J Med 330:1401-1406.
33. Lassmann H, Bancher C, Breitschopf J, Wegiel J, Bobinski M, Jellinger K, Wisnievvski HM. 1995. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89:35-41.
34. Marin P, Maus M, Bockaert J, Glowinski J, Premont J. 1995. Oxygen free radicals enhance the nitric oxide-induced covalent NAD(+)-linkage to neuronal glyceraldehyde-3-phosphate dehydrogenase. Biochem J 309: 891-898.
35. McDonald LJ, Moss J. 1993. Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase. Proc Nad Acad Sci USA 90:6238-6241.
36. Messmer UK, Brune B. 1996. Modification of macrophage glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide. Eur J Pharmacol 302:171-182.
37. Meyer-Siegler K, Mauro DJ, Seal G, Wurzer J, DeRiel JK, Sirover MA. 1991. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Nad Acad Sci USA 88:8460-8464.
38. Morgenegg G, Winkler GC, Hübscher U, Heizmann CW, Mous J, Kuenzle CC. 1986. Glyceraldehyde-3-phosphate dehydrogenase is a non-histone protein and a possible activator of transcription in neurons. J Neurocheni 47:54-62.
39. Moulder KL, Onodera O, Burke JR, Strittmatter WJ, Johnson EM Jr. 1999. Generation of neuronal nuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length. J Neurosci 19:705-715.
40. +-binding region (Rossman fold). J Biol Chem 271:2755-2763.
41. Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, Geller HM, Greene LA. 1998. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci 18:830-840.
42. Paterson IA, Zhang D, Warrington RC, Boulton AA. 1998. R-Deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosme arabinoside but not low extracellular potassium. J Neurochem 70:515-523.
43. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel J-L, Fischbeck KH, Pittman RN. 1997. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19:333-344.
44. Perucho M, Salas J, Salas ML. 1977. Identification of the mammalian DNA-binding protein P8 as glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem 81:557-562.
45. Piechaczyk M, Blanchard JM, Riaad-El Sabouty S, Dani C, Marty L, Jeanteur P. 1984. Unusual abundance of vertebrate 3-phosphate dehydrogenase pseudogenes. Nature 312:469-471.
46. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
47. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. 1995. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15:3775-3787.
48. Ronai Z. 1993. Glycolytic enzymes as DNA binding proteins. Int J Biochem 25:1073-1076.
49. Sánchez I, Xu C-J, Juo P, Kakizaka A, Blenis J, Yuan J. 1999. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22:623-633.
50. Sandou F, Kinkbeiner S, Devys D, Greenberg ME. 1998. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66.
51. Saunders PA, Chalecka-Franaszek E, Chuang D-M. 1997. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arahinoside-induced apoptosis. J Neurocheni 69:1820-1828.
52. Saunders PA, Chen R-W, Chuang D-M. 1999. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J. Neurocheni. 72:925-932.
53. Sawa A, Kahn AA, Hester LD, Snyder SH. 1997. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 94:11669-11674.
54. Schulze H, Schuler A, Stüber D, Döbeli H, Langen H, Huber G. 1993. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain ot Alzheimer's β-amyloid precursor protein. J Neurochem 60:1915-1922.
55. Shashidharan P, Chalmers-Redman RME, Carlile GW, Rodic V, Gurvich N, Yuen T, Tatton WG, Sealfon SC. 1999. Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. NeuroReport 10:1149-1153.
56. Sirover MA. 1999. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-184.
57. Sunaga K, Takahashi H, Chuang D-M, Ishitani R. 1995. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheinier's brain. Neurosci Lett 200:133-136.
58. Tabrizi SJ, Cleeter MWJ, Xuereb J, Taanman JW, Cooper JM, Schapira AHV. 1999. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 45:25-32.
59. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. 1995. DNA end labelling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 133:265-272.
60. Tong L, Toliver-Kinsky T, Taglialatela G, Werrbach-Perez K, Wood T, Perez-Polo JR. 1998. Signal transduction in neuronal death. J Neurochem 71:447-459.
61. 4A ratio in human cell cultures. FEBS Lett 415:160-162.
62. Zeitlin S, Liu J-P, Chapman DL, Papaioannou VE, Efstratiadis A. 1995. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 11:155-163.
63. Zhang D, Berry MD, Paterson IA, Boulton AA. 1999. Two possible sites of action of R-2HMP: changes of mitochondrial membrane potential and sub-cellular GAPDH protein. Soc Neurosci Abs 25:606.18.